159 related articles for article (PubMed ID: 11784144)
21. LQTA-QSAR: a new 4D-QSAR methodology.
Martins JP; Barbosa EG; Pasqualoto KF; Ferreira MM
J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
[TBL] [Abstract][Full Text] [Related]
22. Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods.
Lee KW; Briggs JM
J Comput Aided Mol Des; 2001 Jan; 15(1):41-55. PubMed ID: 11217918
[TBL] [Abstract][Full Text] [Related]
23. A novel logic-based approach for quantitative toxicology prediction.
Amini A; Muggleton SH; Lodhi H; Sternberg MJ
J Chem Inf Model; 2007; 47(3):998-1006. PubMed ID: 17451225
[TBL] [Abstract][Full Text] [Related]
24. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.
Cruciani G; Watson KA
J Med Chem; 1994 Aug; 37(16):2589-601. PubMed ID: 8057302
[TBL] [Abstract][Full Text] [Related]
25. 4D-fingerprints, universal QSAR and QSPR descriptors.
Senese CL; Duca J; Pan D; Hopfinger AJ; Tseng YJ
J Chem Inf Comput Sci; 2004; 44(5):1526-39. PubMed ID: 15446810
[TBL] [Abstract][Full Text] [Related]
26. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
27. A comparison of methods for modeling quantitative structure-activity relationships.
Sutherland JJ; O'Brien LA; Weaver DF
J Med Chem; 2004 Oct; 47(22):5541-54. PubMed ID: 15481990
[TBL] [Abstract][Full Text] [Related]
28. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
[TBL] [Abstract][Full Text] [Related]
29. A new class of glycogen phosphorylase inhibitors.
Lu Z; Bohn J; Bergeron R; Deng Q; Ellsworth KP; Geissler WM; Harris G; McCann PE; McKeever B; Myers RW; Saperstein R; Willoughby CA; Yao J; Chapman K
Bioorg Med Chem Lett; 2003 Nov; 13(22):4125-8. PubMed ID: 14592521
[TBL] [Abstract][Full Text] [Related]
30. Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies.
Taha MO; Habash M; Al-Hadidi Z; Al-Bakri A; Younis K; Sisan S
J Chem Inf Model; 2011 Mar; 51(3):647-69. PubMed ID: 21370899
[TBL] [Abstract][Full Text] [Related]
31. Development of new hydrogen-bond descriptors and their application to comparative molecular field analyses.
Böhm M; Klebe G
J Med Chem; 2002 Apr; 45(8):1585-97. PubMed ID: 11931613
[TBL] [Abstract][Full Text] [Related]
32. Development of quantitative structure-activity relationships and its application in rational drug design.
Yang GF; Huang X
Curr Pharm Des; 2006; 12(35):4601-11. PubMed ID: 17168765
[TBL] [Abstract][Full Text] [Related]
33. 4D-LQTA-QSAR and docking study on potent Gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling.
Ghasemi JB; Safavi-Sohi R; Barbosa EG
Mol Divers; 2012 Feb; 16(1):203-13. PubMed ID: 22127637
[TBL] [Abstract][Full Text] [Related]
34. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
[TBL] [Abstract][Full Text] [Related]
35. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
36. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
37. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
Zhong W; Liu P; Zhang Q; Li D; Lin J
J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
[TBL] [Abstract][Full Text] [Related]
38. Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors.
Birch AM; Kenny PW; Simpson I; Whittamore PR
Bioorg Med Chem Lett; 2009 Feb; 19(3):850-3. PubMed ID: 19103484
[TBL] [Abstract][Full Text] [Related]
39. Quantum mechanics-based properties for 3D-QSAR.
El Kerdawy A; Güssregen S; Matter H; Hennemann M; Clark T
J Chem Inf Model; 2013 Jun; 53(6):1486-502. PubMed ID: 23692495
[TBL] [Abstract][Full Text] [Related]
40. CoRILISA: a local similarity based receptor dependent QSAR method.
Khedkar VM; Coutinho EC
J Chem Inf Model; 2015 Jan; 55(1):194-205. PubMed ID: 25535645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
